[HTML][HTML] Light-based technologies for management of COVID-19 pandemic crisis

CP Sabino, AR Ball, MS Baptista, T Dai… - … of Photochemistry and …, 2020 - Elsevier
The global dissemination of the novel coronavirus disease (COVID-19) has accelerated the
need for the implementation of effective antimicrobial strategies to target the causative agent …

Futuristic role of nanoparticles for treatment of COVID-19

N Thakur, N Thakur, P Chauhan, K Kumar… - Biomaterials and …, 2022 - eaapublishing.org
COVID-19 is a brand new contagious sickness caused by a brand new coronavirus referred
to as intense acute breathing syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a …

Photobiomodulation therapy as a high potential treatment modality for COVID-19

S Soheilifar, H Fathi, N Naghdi - Lasers in Medical Science, 2021 - Springer
COVID-19 is now a worldwide concern, causing an unprecedented pandemic. The infected
cases show different symptoms based on the severity of the disease. In asymptomatic and …

IL-17A both initiates, via IFNγ suppression, and limits the pulmonary type-2 immune response to nematode infection

J Ajendra, AL Chenery, JE Parkinson, BHK Chan… - Mucosal …, 2020 - nature.com
Nippostrongylus brasiliensis is a well-defined model of type-2 immunity but the early lung-
migrating phase is dominated by innate IL-17A production. In this study, we confirm previous …

Photobiomodulation Therapy Restores IL-10 Secretion in a Murine Model of Chronic Asthma: Relevance to the Population of CD4+CD25+Foxp3+ Cells in Lung

AA de Brito, T Gonçalves Santos… - Frontiers in …, 2022 - frontiersin.org
It is largely known that photobiomodulation (PBM) has beneficial effects on allergic
pulmonary inflammation. Our previous study showed an anti-inflammatory effect of the PBM …

Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19

B Aguida, M Pooam, M Ahmad… - … & integrative biology, 2021 - Taylor & Francis
The leading cause of mortality from COVID-19 infection is respiratory distress due to an
exaggerated host immune response, resulting in hyper-inflammation and ensuing cytokine …

[HTML][HTML] Methods of effective low-level laser therapy in the treatment of patients with bronchial asthma (literature review)

SV Moskvin, AA Khadartsev - BioMedicine, 2020 - ncbi.nlm.nih.gov
Bronchial asthma is an autoimmune disease, one of the most common and practically non-
treatable by standard methods. At present, the used drugs only maintain a state of temporary …

Transcutaneous systemic photobiomodulation reduced lung inflammation in experimental model of asthma by altering the mast cell degranulation and interleukin 10 …

PT Alonso, A Schapochnik, S Klein, R Brochetti… - Lasers in Medical …, 2022 - Springer
Asthma is a chronic inflammatory disease characterized by recurrent and reversible
episodes of wheezing, dyspnea, chest stiffness, and cough. Its treatment includes several …

Effect of Low‐Level Laser Therapy (LLLT) in Pulmonary Inflammation in Asthma Induced by House Dust Mite (HDM): Dosimetry Study

NC Rigonato-Oliveira, AA Brito… - International journal …, 2019 - Wiley Online Library
Asthma is characterized by chronic inflammation in the airways. Several models have been
proposed for the discovery of new therapies. Low‐Level Laser Therapy (LLLT) is relatively …

The photobiomodulation of vital parameters of the cancer cell culture by low dose of Near-IR laser irradiation

A Khokhlova, I Zolotovskii, D Stoliarov… - IEEE Journal of …, 2018 - ieeexplore.ieee.org
The mechanisms underlining the cell adaptive and/or activating oxidative stress, called low
level light or photobiomodulation therapies (PBMT), still remain unclear for the near-infrared …